The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Becloneb 400 micrograms/1 ml nebuliser suspension

400 mcg/1
millilitre(s) Nebuliser suspension


Chiesi Farmaceutici S.p.A.PA0584/003/001

Main Information

Trade NameBecloneb 400 micrograms/1 ml nebuliser suspension
Active SubstancesBECLOMETASONE DIPROPIONATE
Strength400 mcg/1
millilitre(s)
Dosage FormNebuliser suspension
Licence HolderChiesi Farmaceutici S.p.A.
Licence NumberPA0584/003/001

Group Information

ATC CodeR03BA Glucocorticoids
R03BA01 beclometasone

Status

Authorised/WithdrawnAuthorised
Licence Issued18/03/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back